Syed Raza, MD
Critical Care Medicine · Riverview, MINPI 1235106915
Payments from drug & device makers
Across 225 payments — averaging $4574.16 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Genentech, Inc.$297K
- GSK$157K
- Sanofi$132K
- Hoffmann-la Roche Limited$126K
- Chiesi USA, Inc.$102K
- Sanofi US Services Inc.$74K
- plus $141K from 18 others
Across 4 payments — averaging $121.26 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- GSK$485
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Genentech, Inc. | 44 | $297,374 |
| GSK | 34 | $156,750 |
| Sanofi | 37 | $132,303 |
| Hoffmann-la Roche Limited | 9 | $125,776 |
| Chiesi USA, Inc. | 30 | $102,206 |
| Sanofi US Services Inc. | 10 | $73,619 |
| AstraZeneca | 5 | $62,884 |
| Verona Pharma, Inc. | 8 | $54,890 |
| Pfizer | 13 | $22,712 |
| Mylan Specialty L.p. | 8 | $185 |
| Actelion Pharmaceuticals US, Inc. | 5 | $96 |
| Boehringer Ingelheim | 4 | $73 |
| AbbVie(2 entities) | 3 | $66 |
| Azurity Pharmaceuticals, Inc. | 3 | $55 |
| Insmed, Inc. | 2 | $36 |
| Mallinckrodt Hospital Products Inc. | 2 | $30 |
| Phathom Pharmaceuticals, Inc. | 1 | $19 |
| Inspire Medical Systems, Inc. | 1 | $19 |
| Electromed, Inc. | 1 | $18 |
| Axsome Therapeutics, Inc. | 1 | $17 |
| Mallinckrodt Enterprises LLC | 1 | $16 |
| Sunovion Pharmaceuticals Inc. | 1 | $14 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $14 |
| Merck | 1 | $13 |
How this compares
$1,029,186 in reported general payments places this provider in the 95th percentile of 177 critical care medicine providers in Michigan.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other critical care medicine in Riverview
- Asker AsmiRiverview$11K
- Jason WellsGrand Rapids$2.8M
- Kevin PattersonGrand Rapids$151K
- Angel Peralta-AvilaDetroit$147K
- Moumen AsbahiTroy$81K
- Rana AwdishDetroit$46K
- Mujahed AbbasLansing$28K
- Rajit PahwaLansing$20K
- Abdulrazak AlchakakiSouthfield$19K
- Narayana GandhamSaint Joseph$18K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.